{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:24Z","timestamp":1792788144095,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673374"],"award-info":[{"award-number":["81673374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071890"],"award-info":[{"award-number":["82071890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101144"],"award-info":[{"award-number":["32101144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for HUST Academic Frontier Youth Team","award":["2018QYTD13"],"award-info":[{"award-number":["2018QYTD13"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB301"],"award-info":[{"award-number":["2020CFB301"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conventional chemotherapy has poor efficacy in triple-negative breast cancer (TNBC) which is highly heterogeneous and aggressive. Imaging-guided therapy is usually combined with diverse treatment modalities, could realize the integration of diagnosis and treatments. Therefore, the primary challenge for combinational therapy is designing proper delivery systems to accomplish multiple synergistic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Herein, a facile nanoplatform was manufactured to fulfill the all-in-one approaches for TNBC combinational therapy. Fe\n                      <jats:sup>3+<\/jats:sup>\n                      -based metal-phenolic networks (MPNs) with bovine serum albumin (BSA) modification served as drug delivery carriers to encapsulate bleomycin (BLM), forming BFE@BSA NPs. The self-assembly mechanism, pH-responsive drug release behavior, and other physicochemical properties of this system were characterized. The potential of BFE@BSA NPs as photothermal transduction agents and magnetic resonance imaging (MRI) contrast agents was explored. The synergistic anti-tumor effects consisting of BLM-induced chemotherapy, Fenton reactions-mediated chemodynamic therapy, and photothermal therapy-induced apoptosis were studied both in vitro and in vivo. Once internalized into tumor cells, released BLM could cause DNA damage, while Fenton reactions were initiated to produce highly toxic \u2022OH. Upon laser irradiation, BFE@BSA NPs could convert light into heat to achieve synergistic effects. After intravenous administration, BFE@BSA NPs exhibited great therapeutic effects in 4T1 tumor xenograft model. Moreover, as T\n                      <jats:sub>1<\/jats:sub>\n                      -weighted MRI contrast agents, BFE@BSA NPs could provide diagnosis and treatment monitoring for individualized precise therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A nano-system that integrated imaging and combinational therapy (chemotherapy, chemodynamic therapy and photothermal therapy) were developed to kill the tumor and monitor therapeutic efficacy. This strategy provided an all-in-one theranostic nanoplatform for MRI-guided combinational therapy against TNBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-022-01416-7","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T07:04:04Z","timestamp":1652339044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Qi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conglian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438\u201351.","journal-title":"CA Cancer J Clin"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA"},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","volume":"7","author":"L Carey","year":"2010","unstructured":"Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7:683\u201392.","journal-title":"Nat Rev Clin Oncol"},{"key":"1416_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"1416_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.bioactmat.2020.10.020","volume":"6","author":"G Shu","year":"2021","unstructured":"Shu G, Chen M, Song J, Xu X, Lu C, Du Y, Xu M, Zhao Z, Zhu M, Fan K, et al. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe(3+) as a novel theranostic agent for T1\/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer. Bioact Mater. 2021;6:1423\u201335.","journal-title":"Bioact Mater"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","volume":"13","author":"LA Carey","year":"2007","unstructured":"Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007;13:2329\u201334.","journal-title":"Clin Cancer Res"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies. Lancet. 2017;389:2430\u201342.","journal-title":"The Lancet"},{"key":"1416_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.tips.2015.08.009","volume":"36","author":"M Kalimutho","year":"2015","unstructured":"Kalimutho M, Parsons K, Mittal D, L\u00f3pez JA, Srihari S, Khanna KK. Targeted therapies for triple-negative breast cancer: combating a stubborn disease. Trends Pharmacol Sci. 2015;36:822\u201346.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"1416_CR10","doi-asserted-by":"publisher","first-page":"e2005062","DOI":"10.1002\/adma.202005062","volume":"33","author":"H Hu","year":"2021","unstructured":"Hu H, Feng W, Qian X, Yu L, Chen Y, Li Y. Emerging nanomedicine-enabled\/enhanced nanodynamic therapies beyond traditional photodynamics. Adv Mater. 2021;33(12):e2005062.","journal-title":"Adv Mater"},{"key":"1416_CR11","doi-asserted-by":"publisher","first-page":"2100243","DOI":"10.1002\/adfm.202100243","volume":"31","author":"SL Li","year":"2021","unstructured":"Li SL, Jiang P, Jiang FL, Liu Y. Recent advances in nanomaterial-based nanoplatforms for chemodynamic cancer therapy. Adv Func Mater. 2021;31:2100243.","journal-title":"Adv Func Mater"},{"key":"1416_CR12","doi-asserted-by":"publisher","first-page":"213828","DOI":"10.1016\/j.ccr.2021.213828","volume":"437","author":"X Zhong","year":"2021","unstructured":"Zhong X, Wang X, Li J, Hu J, Cheng L, Yang X. ROS-based dynamic therapy synergy with modulating tumor cell-microenvironment mediated by inorganic nanomedicine. Coord Chem Rev. 2021;437:213828.","journal-title":"Coord Chem Rev"},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12951-019-0501-3","volume":"17","author":"W Tang","year":"2019","unstructured":"Tang W, Gao H, Ni D, Wang Q, Gu B, He X, Peng W. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy. J Nanobiotechnology. 2019;17:68.","journal-title":"J Nanobiotechnology"},{"key":"1416_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12951-019-0507-x","volume":"17","author":"B Zhao","year":"2019","unstructured":"Zhao B, Zhao P, Jin Z, Fan M, Meng J, He Q. Programmed ROS\/CO-releasing nanomedicine for synergetic chemodynamic-gas therapy of cancer. J Nanobiotechnology. 2019;17:75.","journal-title":"J Nanobiotechnology"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/anie.201805664","volume":"58","author":"Z Tang","year":"2019","unstructured":"Tang Z, Liu Y, He M, Bu W. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew Chem Int Ed Engl. 2019;58:946\u201356.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.023","volume":"211","author":"X Qian","year":"2019","unstructured":"Qian X, Zhang J, Gu Z, Chen Y. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy. Biomaterials. 2019;211:1\u201313.","journal-title":"Biomaterials"},{"key":"1416_CR17","doi-asserted-by":"publisher","first-page":"e1614","DOI":"10.1002\/wnan.1614","volume":"12","author":"W Wang","year":"2020","unstructured":"Wang W, Jin Y, Xu Z, Liu X, Bajwa SZ, Khan WS, Yu H. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1614.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1416_CR18","doi-asserted-by":"publisher","first-page":"100946","DOI":"10.1016\/j.nantod.2020.100946","volume":"35","author":"X Wang","year":"2020","unstructured":"Wang X, Zhong X, Liu Z, Cheng L. Recent progress of chemodynamic therapy-induced combination cancer therapy. Nano Today. 2020;35:100946.","journal-title":"Nano Today"},{"issue":"3","key":"1416_CR19","doi-asserted-by":"crossref","first-page":"e1682","DOI":"10.1002\/wnan.1682","volume":"13","author":"J Yao","year":"2020","unstructured":"Yao J, Zheng F, Yao C, Xu X, Akakuru OU, Chen T, Yang F, Wu A. Rational design of nanomedicine for photothermal-chemodynamic bimodal cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;13(3):e1682.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1416_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7150\/thno.14988","volume":"6","author":"L Zou","year":"2016","unstructured":"Zou L, Wang H, He B, Zeng L, Tan T, Cao H, He X, Zhang Z, Guo S, Li Y. Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics. Theranostics. 2016;6:762\u201372.","journal-title":"Theranostics"},{"key":"1416_CR21","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1039\/C8CS00618K","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2019;48:2053\u2013108.","journal-title":"Chem Soc Rev"},{"key":"1416_CR22","first-page":"e20001207","volume":"10","author":"J Liu","year":"2021","unstructured":"Liu J, Shi J, Nie W, Wang S, Liu G, Cai K. Recent progress in the development of multifunctional nanoplatform for precise tumor phototherapy. Adv Healthc Mater. 2021;10:e20001207.","journal-title":"Adv Healthc Mater"},{"key":"1416_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","volume":"31","author":"JD Schoenfeld","year":"2017","unstructured":"Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, et al. O2(-) and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 2017;31:487-500 e488.","journal-title":"Cancer Cell"},{"key":"1416_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1416_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9\u201317.","journal-title":"Nat Chem Biol"},{"key":"1416_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1126\/science.1237265","volume":"341","author":"H Ejima","year":"2013","unstructured":"Ejima H, Richardson JJ, Liang K, Best JP, van Koeverden MP, Such GK, Cui J, Caruso F. One-step assembly of coordination complexes for versatile film and particle engineering. Science. 2013;341:154\u20137.","journal-title":"Science"},{"key":"1416_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acs.accounts.0c00150","volume":"53","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lin Z, Ju Y, Rahim MA, Richardson JJ, Caruso F. Polyphenol-mediated assembly for particle engineering. Acc Chem Res. 2020;53:1269\u201378.","journal-title":"Acc Chem Res"},{"key":"1416_CR28","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1038\/ncomms9003","volume":"6","author":"F Liu","year":"2015","unstructured":"Liu F, He X, Chen H, Zhang J, Zhang H, Wang Z. Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications. Nat Commun. 2015;6:8003.","journal-title":"Nat Commun"},{"key":"1416_CR29","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cej.2021.131420","volume":"425","author":"L Shang","year":"2021","unstructured":"Shang L, Yang T, Yang C, Li Z, Kong L, Zhang Z. Metal ions-mediated self-assembly of nanomedicine for combinational therapy against triple-negative breast cancer. Chem Eng J. 2021;425:1420.","journal-title":"Chem Eng J"},{"key":"1416_CR30","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/anie.201807804","volume":"58","author":"MA Rahim","year":"2019","unstructured":"Rahim MA, Kristufek SL, Pan S, Richardson JJ, Caruso F. Phenolic building blocks for the assembly of functional materials. Angew Chem Int Ed Engl. 2019;58:1904\u201327.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1416_CR31","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.7150\/thno.31847","volume":"9","author":"Q Dai","year":"2019","unstructured":"Dai Q, Geng H, Yu Q, Hao J, Cui J. Polyphenol-based particles for theranostics. Theranostics. 2019;9:3170\u201390.","journal-title":"Theranostics"},{"key":"1416_CR32","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.7150\/thno.58711","volume":"11","author":"W Xie","year":"2021","unstructured":"Xie W, Guo Z, Zhao L, Wei Y. Metal-phenolic networks: facile assembled complexes for cancer theranostics. Theranostics. 2021;11:6407\u201326.","journal-title":"Theranostics"},{"key":"1416_CR33","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.1002\/anie.201904880","volume":"58","author":"P Zhang","year":"2019","unstructured":"Zhang P, Hou Y, Zeng J, Li Y, Wang Z, Zhu R, Ma T, Gao M. Coordinatively unsaturated Fe(3+) based activatable probes for enhanced MRI and therapy of tumors. Angew Chem Int Ed Engl. 2019;58:11088\u201396.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1416_CR34","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1021\/acsnano.8b01456","volume":"12","author":"T Liu","year":"2018","unstructured":"Liu T, Zhang M, Liu W, Zeng X, Song X, Yang X, Zhang X, Feng J. Metal ion\/tannic acid assembly as a versatile photothermal platform in engineering multimodal nanotheranostics for advanced applications. ACS Nano. 2018;12:3917\u201327.","journal-title":"ACS Nano"},{"key":"1416_CR35","doi-asserted-by":"publisher","first-page":"102071","DOI":"10.1016\/j.nano.2019.102071","volume":"23","author":"C Zhang","year":"2020","unstructured":"Zhang C, Li J, Yang C, Gong S, Jiang H, Sun M, Qian C. A pH-sensitive coordination polymer network-based nanoplatform for magnetic resonance imaging-guided cancer chemo-photothermal synergistic therapy. Nanomedicine. 2020;23:102071.","journal-title":"Nanomedicine"},{"key":"1416_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"1416_CR37","doi-asserted-by":"publisher","first-page":"e2007356","DOI":"10.1002\/adma.202007356","volume":"33","author":"Y Guo","year":"2021","unstructured":"Guo Y, Sun Q, Wu FG, Dai Y, Chen X. Polyphenol-containing nanoparticles: synthesis, properties, and therapeutic delivery. Adv Mater. 2021;33:e2007356.","journal-title":"Adv Mater"},{"key":"1416_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc1547","volume":"5","author":"J Chen","year":"2005","unstructured":"Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer. 2005;5:102\u201312.","journal-title":"Nat Rev Cancer"},{"key":"1416_CR39","doi-asserted-by":"publisher","first-page":"213339","DOI":"10.1016\/j.ccr.2020.213339","volume":"417","author":"U Basu","year":"2020","unstructured":"Basu U, Roy M, Chakravarty AR. Recent advances in the chemistry of iron-based chemotherapeutic agents. Coord Chem Rev. 2020;417:213339.","journal-title":"Coord Chem Rev"},{"key":"1416_CR40","doi-asserted-by":"publisher","first-page":"e65181","DOI":"10.1371\/journal.pone.0065181","volume":"8","author":"H Bugaut","year":"2013","unstructured":"Bugaut H, Bruchard M, Berger H, Derangere V, Odoul L, Euvrard R, Ladoire S, Chalmin F, Vegran F, Rebe C, et al. Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. PLoS ONE. 2013;8:e65181.","journal-title":"PLoS ONE"},{"issue":"326","key":"1416_CR41","doi-asserted-by":"publisher","first-page":"326ra20","DOI":"10.1126\/scitranslmed.aad7785","volume":"8","author":"O Burgy","year":"2016","unstructured":"Burgy O, Wettstein G, Bellaye PS, Decologne N, Racoeur C, Goirand F, Beltramo G, Hernandez J-F, Kenani A, Camus P, et al. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity. Sci Transl Med. 2016;8(326):326ra20.","journal-title":"Sci Transl Med"},{"key":"1416_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1568009616666151130213910","volume":"16","author":"Z Yu","year":"2016","unstructured":"Yu Z, Yan B, Gao L, Dong C, Zhong J, Do M, Nguyen B, Seong Lee S, Hu X, Liang F. Targeted delivery of bleomycin: a comprehensive anticancer review. Curr Cancer Drug Targets. 2016;16:509\u201321.","journal-title":"Curr Cancer Drug Targets"},{"key":"1416_CR43","doi-asserted-by":"publisher","first-page":"15685","DOI":"10.1039\/C7NR05003H","volume":"9","author":"Q Feng","year":"2017","unstructured":"Feng Q, Zhang W, Li Y, Yang X, Hao Y, Zhang H, Li W, Hou L, Zhang Z. An intelligent NIR-responsive chelate copper-based anticancer nanoplatform for synergistic tumor targeted chemo-phototherapy. Nanoscale. 2017;9:15685\u201395.","journal-title":"Nanoscale"},{"key":"1416_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.canlet.2012.06.008","volume":"334","author":"A Koshkaryev","year":"2013","unstructured":"Koshkaryev A, Piroyan A, Torchilin VP. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Cancer Lett. 2013;334:293\u2013301.","journal-title":"Cancer Lett"},{"key":"1416_CR45","doi-asserted-by":"publisher","first-page":"8897","DOI":"10.1002\/anie.201003316","volume":"49","author":"T Georgelin","year":"2010","unstructured":"Georgelin T, Bombard S, Siaugue JM, Cabuil V. Nanoparticle-mediated delivery of bleomycin. Angew Chem Int Ed Engl. 2010;49:8897\u2013901.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1416_CR46","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1002\/anie.202002089","volume":"59","author":"Y Han","year":"2020","unstructured":"Han Y, Lin Z, Zhou J, Yun G, Guo R, Richardson JJ, Caruso F. Polyphenol-mediated assembly of proteins for engineering functional materials. Angew Chem Int Ed Engl. 2020;59:15618\u201325.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1416_CR47","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1021\/acs.nanolett.9b04147","volume":"19","author":"MS Taha","year":"2019","unstructured":"Taha MS, Cresswell GM, Park J, Lee W, Ratliff TL, Yeo Y. Sustained delivery of carfilzomib by tannic acid-based nanocapsules helps develop antitumor immunity. Nano Lett. 2019;19:8333\u201341.","journal-title":"Nano Lett"},{"key":"1416_CR48","first-page":"134","volume":"28","author":"J Li","year":"2021","unstructured":"Li J, Jiang X, Shang L, Li Z, Yang C, Luo Y, Hu D, Shen Y, Zhang Z. L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent. Drug Deliv. 2021;28:134\u201343.","journal-title":"Drug Deliv"},{"key":"1416_CR49","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.7150\/thno.41882","volume":"10","author":"Q Tian","year":"2020","unstructured":"Tian Q, An L, Tian Q, Lin J, Yang S. Ellagic acid-Fe@BSA nanoparticles for endogenous H2S accelerated Fe(III)\/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy. Theranostics. 2020;10:4101\u201315.","journal-title":"Theranostics"},{"key":"1416_CR50","doi-asserted-by":"publisher","first-page":"9513","DOI":"10.2147\/IJN.S215883","volume":"14","author":"S Zheng","year":"2019","unstructured":"Zheng S, Zhang M, Bai H, He M, Dong L, Cai L, Zhao M, Wang Q, Xu K, Li J. Preparation of AS1411 aptamer modified Mn-MoS2 QDs for targeted MR imaging and fluorescence labelling of renal cell carcinoma. Int J Nanomedicine. 2019;14:9513\u201324.","journal-title":"Int J Nanomedicine"},{"key":"1416_CR51","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s40843-020-1434-1","volume":"64","author":"L An","year":"2020","unstructured":"An L, Cai Y, Tian Q, Lin J, Yang S. Ultrasensitive iron-based magnetic resonance contrast agent constructed with natural polyphenol tannic acid for tumor theranostics. Sci China Mater. 2020;64:498\u2013509.","journal-title":"Sci China Mater"},{"key":"1416_CR52","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1021\/acsami.9b23084","volume":"12","author":"K Tu","year":"2020","unstructured":"Tu K, Deng H, Kong L, Wang Y, Yang T, Hu Q, Hu M, Yang C, Zhang Z. Reshaping tumor immune microenvironment through acidity-responsive nanoparticles featured with CRISPR\/Cas9-mediated programmed death-ligand 1 attenuation and chemotherapeutics-induced immunogenic cell death. ACS Appl Mater Interfaces. 2020;12:16018\u201330.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1416_CR53","first-page":"9","volume":"2020","author":"Q Hu","year":"1858","unstructured":"Hu Q, Shang L, Wang M, Tu K, Hu M, Yu Y, Xu M, Kong L, Guo Y, Zhang Z. Co-delivery of paclitaxel and interleukin-12 regulating tumor microenvironment for cancer immunochemotherapy. Adv Healthc Mater. 1858;2020:9.","journal-title":"Adv Healthc Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01416-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T07:31:24Z","timestamp":1700551884000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01416-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01416-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the principles from the Institutional Animal Care and Use Committee (IACUC) of HUST. All animal experiments were reviewed and approved by the IACUC of HUST (IACUC Number: S2556).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}